Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: Focus on adenosine diphosphate receptor inhibitors

被引:11
|
作者
Ogawa, Hisao [1 ]
Hokimoto, Seiji [1 ]
Kaikita, Koichi [1 ]
Yamamoto, Koichiro [1 ]
Chitose, Tadasuke [1 ]
Ono, Takamichi [1 ]
Tsujita, Kenichi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan
关键词
Cardiovascular disease; Platelet inhibitors; Thrombosis; Drug therapy; Adenosine diphosphate; ELEVATION MYOCARDIAL-INFARCTION; ASPIRIN-TREATED PATIENTS; PROTON PUMP INHIBITORS; INDUCED HEPATOTOXICITY; STENT IMPLANTATION; DIABETES-MELLITUS; AMERICAN-COLLEGE; HEALTHY CHINESE; ARTERY-DISEASE; DOUBLE-BLIND;
D O I
10.1016/j.jjcc.2011.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dual antiplatelet therapy with aspirin and clopidogrel is routinely used to prevent thrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) in Japan. However, these agents have various limitations and some patients will experience further cardiovascular events. The purpose of this article is to review the antiplatelet agents currently used in patients undergoing PCI in Japan, to discuss the issues and limitations associated with these antiplatelet agents, and to characterize new antiplatelet agents currently under investigation in Japan. Particular emphasis is placed on the novel thienopyridine prasugrel, and the potential this drug has for overcoming the issues associated with other antiplatelet agents. (C) 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:6 / 17
页数:12
相关论文
共 50 条
  • [1] Post percutaneous coronary intervention antiplatelet therapy: Current perceptions, prospects and perplexity
    Pant, Sadip
    Neupane, Pritam
    Ramesh, K. C.
    Barakoti, Murari
    CARDIOLOGY JOURNAL, 2011, 18 (06) : 712 - 717
  • [2] Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives
    Natsuaki, Masahiro
    Sonoda, Shinjo
    Yoshioka, Goro
    Hongo, Hiroshi
    Kaneko, Tetsuya
    Kashiyama, Kuninobu
    Yokoi, Kensuke
    Hikichi, Yutaka
    Node, Koichi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (02) : 255 - 263
  • [3] Emerging Antiplatelet Therapies in Percutaneous Coronary Intervention: A Focus on Prasugrel
    Martin, Michelle T.
    Spinier, Sarah A.
    Nutescu, Edith A.
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 425 - 442
  • [4] Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome)
    Fosbol, Emil L.
    Ju, Christine
    Anstrom, Kevin J.
    Zettler, Marjorie E.
    Messenger, John C.
    Waksman, Ron
    Effron, Mark B.
    Baker, Brian A.
    Cohen, David J.
    Peterson, Eric D.
    Wang, Tracy Y.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (11)
  • [5] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
  • [6] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [7] Antiplatelet therapy after coronary intervention in Asia and Japan The Asian perspective of antiplatelet intervention
    Goto, S.
    Toda, E.
    HAMOSTASEOLOGIE, 2009, 29 (04): : 321 - 325
  • [8] Prasugrel as Antiplatelet Therapy in Patients With Acute Coronary Syndromes or Undergoing Percutaneous Coronary Intervention
    Fletcher, Barbara
    Thalinger, Karen K.
    CRITICAL CARE NURSE, 2010, 30 (05) : 45 - 54
  • [9] Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk
    Spinler, Sarah A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S7 - S17
  • [10] Antiplatelet therapy after percutaneous coronary intervention
    Angiolillo, Dominick J.
    Galli, Mattia
    Collet, Jean-Philippe
    Kastrati, Adnan
    O'Donoghue, Michelle L.
    EUROINTERVENTION, 2022, 17 (17) : E1371 - E1396